The methodology, interpretation, and clinical significance of Franz diffusion cell studies — the gold standard for quantifying transdermal active ingredient flux in professional skincare formulations.
The Franz diffusion cell, developed by Thomas J. Franz in 1975, is the industry-standard in vitro model for measuring transdermal and dermal drug and cosmeceutical delivery. The apparatus consists of two chambers separated by a membrane of excised skin tissue (human or porcine): a donor compartment into which the test formulation is applied, and a receiver compartment filled with physiological receptor fluid (typically phosphate-buffered saline with 4% PEG 400) that mimics dermal tissue conditions.
Over a defined time period, the receiver fluid is sampled at intervals, and the active ingredient concentration in each sample is quantified by HPLC or LC-MS/MS. The resulting data generates a time-resolved permeation profile — showing cumulative dose delivered per unit area, lag time before steady-state flux begins, and the maximum flux rate achieved.
Any cosmeceutical or medical-grade skincare product claiming transdermal delivery — as opposed to surface-level application — should be supported by Franz diffusion cell data or equivalent in vitro permeation testing. Without this data, "penetrates the skin" and "reaches the dermis" are marketing assertions with no scientific basis. With Franz cell data, specific claims can be made: what percentage of the applied dose reaches the viable epidermis or dermis, at what time post-application, and whether the delivered concentration falls within the pharmacologically active range for the active in question.
Franz diffusion cell studies comparing identical active concentrations in patch versus serum format consistently demonstrate 3–8× higher cumulative dermal delivery from patch formulations over equivalent time periods. The kinetic advantage is mechanistically clear: serum vehicles lose their concentration gradient within minutes of application as the vehicle evaporates, collapsing the driving force for diffusion. An HPMC hydrogel patch maintains a constant-concentration donor reservoir against the skin surface for the full wear period, sustaining near-steady-state flux throughout.
Explore the GHK-CU SNAP 8 Facial Microneedle Patch →